Glatiramer Acetate injection bulk supplier for pharma manufacturers

Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL Suppliers & Bulk Manufacturers

Available Forms: SQ injection

Available Strengths: 20 mg/mL, 40 mg/mL

Reference Brands: Copaxone(US)

Glatiramer Acetate modulates the immune system by shifting T-cell responses from pro-inflammatory to anti-inflammatory, reducing autoimmune attack on the nervous system. It decreases relapse frequency, slows disease progression, and minimizes lesion development in multiple sclerosis. Benefits include improved symptom control, fewer relapses, and enhanced quality of life for MS patients.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Glatiramer Acetate, marketed as Copaxone, is approved in the US by the FDA and in the EU via EMA for multiple sclerosis. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and manufacturing details, while the EMA ensures compliance with regional safety and quality standards.

Glatiramer Acetate Injection — third party manufacturing & bulk supply

Glatiramer Acetate Injection 20 mg/mL, 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Glatiramer Acetate Injection is supplied as SQ injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glatiramer Acetate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Glatiramer Acetate Injection →

Back to Listing

Frequently Asked Questions

Glatiramer Acetate injection is listed as SQ injection in 20 mg/mL, 40 mg/mL. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Glatiramer Acetate injection is referenced against Copaxone(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.